Dimercaptosuccinic Acid: A Multifunctional Cost Effective Agent for Imaging and Therapy

Overview

Journal Indian J Nucl Med

Specialty Nuclear Medicine

Date 2015 Oct 3

PMID 26430311

Citations 3

Authors

Jaya Shukla

Bhagwant Rai Mittal

Affiliations

Soon will be listed here.

Abstract

Dimercaptosuccinic acid (DMSA) is an analog of dimercaprol used as metal chelating moiety in variety of conditions. In nuclear medicine itself two types of Tc-99m DMSA complexes are used, trivalent and pentavalent forms. In this review, we have discussed the mechanism of uptake of both complexes as well as diagnostic and therapeutic application in a clinical scenario.

Citing Articles

Contrast-enhanced voiding ultrasonography to detect intrarenal reflux in children: comparison with 99mTc-DMSA renal scans.

Oh S, Ha J, Cho Y Ultrasonography. 2022; 41(3):502-510.

PMID: 35295068 PMC: 9262665. DOI: 10.14366/usg.21143.

THE ROLE OF TUMOR-SEEKING RADIOPHARMACEUTICALS IN THE DIAGNOSIS AND MANAGEMENT OF ADRENAL TUMORS.

Vukomanovic V, Matovic M, Djukic A, Ignjatovic V, Vuleta K, Djukic S Acta Endocrinol (Buchar). 2020; 16(3):316-323.

PMID: 33363653 PMC: 7748228. DOI: 10.4183/aeb.2020.316.

Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.

Vukomanovic V, Matovic M, Doknic M, Ignjatovic V, Vukomanovic I, Djukic S Nucl Med Commun. 2018; 40(1):41-51.

PMID: 30334858 PMC: 6282662. DOI: 10.1097/MNM.0000000000000931.

References

van Luijk W, Ensing G, Meijer S, Donker A, Piers D . Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction?. Eur J Nucl Med. 1984; 9(10):439-42. DOI: 10.1007/BF00563165. View

Kobayashi H, Kotoura Y, Sakahara H, Yamamuro T, Endo K, Konishi J . Solitary muscular sarcoidosis: CT, MRI, and scintigraphic characteristics. Skeletal Radiol. 1994; 23(4):293-5. DOI: 10.1007/BF02412364. View

Lee B, Chiu N, Wu D, Tsai K, Liu G, Yu H . Use of 99mTc (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy. Radiology. 2001; 220(2):381-5. DOI: 10.1148/radiology.220.2.r01au30381. View

Clarke S, Lazarus C, Mistry R, Maisey M . The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol. 1987; 60(719):1089-92. DOI: 10.1259/0007-1285-60-719-1089. View

Watkinson J, Lazarus C, Mistry R, Shaheen O, Maisey M, Clarke S . Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging. J Nucl Med. 1989; 30(2):174-80. View

Blower P, Singh J, Clarke S . The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med. 1991; 32(5):845-9. View

Nakamoto Y, Sakahara H, Kobayashi H, Saga T, Tsuboyama N, Nakamura T . Technetium-99m (V)-dimercaptosuccinic acid: normal accumulation in the breasts. Eur J Nucl Med. 1997; 24(9):1146-8. DOI: 10.1007/BF01254247. View

Banci M, Bianchi P, Gianni W, Romani A, De Vincentis G, Ierardi M . Preliminary evaluation of the usefulness of Tc-99m (V) DMSA in pancreatic neuroendocrine tumors. Clin Nucl Med. 1996; 21(2):122-4. DOI: 10.1097/00003072-199602000-00009. View

Akbunar A, Orhan B, Alper E . Bone-scan-like pattern with 99Tcm(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism. Nucl Med Commun. 2000; 21(2):181-5. DOI: 10.1097/00006231-200002000-00010. View

10.

Mojiminiyi O, Udelsman R, Soper N, Shepstone B, DUDLEY N . Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med. 1991; 16(4):259-62. View

11.

Zhang Y, Guo C, Yu G, Ma D, Li Q, Zhang C . [Application of 99mTc(V)-dimercaptosuccinic acid imaging in detecting neck metastases in patients with oral squamous cell carcinoma]. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004; 39(7):425-8. View

12.

Wu X, Lin G, Zhang Q . [Evaluation of clinical value of technetium-99m(V) dimercaptosuccinic acid SPECT in diagnosis of parotid lump]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2002; 34(6):334-6. View

13.

Bandopadhyaya G, Gupta P, Singh A, Shukla J, Rastogi S, Kumar R . (99m)Tc-DMSA (V) in Evaluation of Osteosarcoma: Comparative Studies with (18)F-FDG PET/CT in Detection of Primary and Malignant Lesions. ISRN Oncol. 2012; 2012:371830. PMC: 3356905. DOI: 10.5402/2012/371830. View

14.

Tannock I, Rotin D . Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989; 49(16):4373-84. View

15.

Kavanaugh M, Kabat D . Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int. 1996; 49(4):959-63. DOI: 10.1038/ki.1996.135. View

16.

Adams J, Baral M, Geis E, Mitchell J, Ingram J, Hensley A . Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. BMC Clin Pharmacol. 2009; 9:16. PMC: 2774660. DOI: 10.1186/1472-6904-9-16. View

17.

Adalet I, Demirkale P, Unal S, Ouz H, Alagol F, Cantez S . Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201. Clin Nucl Med. 1999; 24(9):678-83. DOI: 10.1097/00003072-199909000-00008. View

18.

Lee B, Chiu N, Chang J, Liu G, Yu H . Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection. J Nucl Med. 1998; 39(12):2128-31. View

19.

Ambrus E, Rajtar M, Ormandi K, Sera T, TOSZEGI A, LANG J . Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Anticancer Res. 1997; 17(3B):1599-605. View

20.

Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar U, Zhu H . Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions. J Nucl Med. 2002; 43(7):882-8. View